retatrutide mechanism retatrutide clinical trials 2024 2025 of subcutaneous tirzepatide, retatrutide, and Retatrutide, an experimental weight-loss drug,

Understanding your personal genetics may help your healthcare team optimize your overall treatment approach, including contraception strategy

Red meat in large quantities can contribute to constipation due to its lack of fiber and longer digestion time

For metabolic health and insulin resistance, the evidence supports a moderate dose approach in the 5 mg range, dosed five times per week, combined with a structured exercise program

During a video consultation, your MDWatch provider reviews your medical history, current medications, and goals to determine whether GLP1 + GIP is appropriate

Retatrutide is a triple agonist for GLP-1, GIP, and glucagon receptors, which produces its superior weight loss results compared to single or dual agonists